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Cancer of the larynx is one of the more common malignancies in
England and Wales (ranking 20th in both sexes combined).
Approximately 1800 new cases are diagnosed each year, 80% of
them in men. Incidence rates are approximately 6.2 and 1.3 per
100 000 per year in men and women, respectively. Incidence has
fallen by approximately 5% in men over the last decade, but little
change has occurred in women. Laryngeal cancer is rare under the
age of 40, but the risk rises rapidly with age. There is a marked
socioeconomic gradient, with risk twice as high in the most
deprived groups as in the most affluent groups (Quinn et al, 2001).
Geographic variation in risk is also wide, with incidence less than
70% of the United Kingdom and Ireland average in southwest
England and parts of the southeast, but 50% or more above the
average in much of Scotland and in the main urban areas of
northwest and northeast England. The combined effect is a striking
regional disparity in the socioeconomic profile of the disease. In the
Oxford region, for example, 50% of cases occur in affluent groups,
although in the West Midlands and the northwest, that proportion is
approximately 20%, with 65% of cases among the most deprived
(data not shown). The annual death rate of laryngeal cancer in
England and Wales is approximately 2.3 per 100 000 in men (570
deaths a year) and 0.6 in women (150 deaths a year).
The main risk factors for laryngeal cancer are alcohol and
tobacco, and their effects are synergistic (Tuyns and Audigier,
1976; Tuyns et al, 1988). Tobacco dominates the risk for cancers of
the vocal cords and glottis, whereas alcohol is more prominent for
cancers of the supraglottis. This has a direct impact on survival in
men and women for all laryngeal cancers combined, because the
main causal exposures and the most common anatomic location of
tumours within the larynx differ between the sexes, as do their
diagnosis, treatment and outcome. Glottal cancers are more
common in men; they give rise to hoarseness when the tumour
is still small. They can often be treated surgically and are
responsive to radiotherapy. They tend to have higher survival
than supraglottic tumours. Cancers of the supraglottis are more
common in women and do not give rise to early symptoms of
hoarseness. Diagnosis from dysphagia or sore throat is often later
than for cancers of the glottis, curative radiotherapy and surgery
may be less successful, and survival is lower.
Survival analyses are reported here only for men. Some 20 000
men were diagnosed with a first, primary, invasive malignancy of
the larynx in England and Wales during the period 1986–1999,
and followed up to the end of 2001, approximately 89% of those
eligible for analysis. Approximately 2% were excluded because
their vital status was unknown on 5 November 2002, when the data
were extracted for analysis; 4% because the laryngeal cancer was
not their first primary cancer and another 4% because their
survival was zero or unknown, most of whom were registered from
a death certificate only.
Half (49%) of the laryngeal tumours diagnosed in men during
the 1990s arose in the glottis (endolarynx), including the vocal
cords. The increase of approximately 5% since the 1980s is
matched by a similar drop in the proportion of tumours of
unspecified subsite (down to 31%), suggesting gradual improve-
ment in diagnostic precision. Approximately 16% arose in the
supraglottis (epilarynx). Tumours of the larynx below the cords
(subglottis) remained rare (1.3%). Almost 85% of laryngeal
tumours diagnosed during the 1990s were squamous carcinomas,
an increase of 6% since the 1980s, matched by a similar fall in the
proportion coded as carcinoma without further specification
(down to 7%), again suggesting improved precision of pathology.
Verrucous carcinoma was specified as often in the 1990s alone (125
cases, 1%) as in the earlier two decades combined (130 cases,
0.4%), but adenocarcinoma remains rare (0.3%).
SURVIVAL TRENDS
Relative survival from laryngeal cancer in men diagnosed during
the 1990s was only slightly higher than for men diagnosed during
the late 1980s, at approximately 84, 64 and 54% at 1, 5 and 10
years, respectively (Table 1 and Figure 1). After adjustment for
deprivation, however, the estimate of trend in 5-year survival was
an increase of 3.3% every 5 years between 1986– 1990 and 1996–
1999, a trend of borderline significance (95% confidence interval
0.0–6.7%). This rate of increase in survival is adjusted for the
deprivation gap in survival and for any changes in the distribution
of patients by deprivation category, and it is a more reliable
estimate of the trend in survival than would appear from the very
similar survival of 63–64% in successive calendar periods.
Predicted survival derived from the hybrid approach
(Brenner and Rachet, 2004) using survival probabilities observed
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during 2000–2001 does not suggest any imminent increase in
survival.
DEPRIVATION
Five-year survival was 17% lower (95% confidence interval 12–22%
lower) among men diagnosed in the most deprived group in
1996– 1999 than those in the most affluent group (Table 2,
Figure 2). This is the steepest socioeconomic gradient in survival
among all 20 common cancers that we examined, and it has
widened more rapidly – by 3.7% every 5 years – than for any other
cancer in men, even prostate cancer (q.v.). Figure 2 shows
that virtually all the overall increase in 5-year survival between
1986– 1990 and 1996– 1999 occurred among the more affluent
groups, while it stagnated or even fell slightly amongst men in the
more deprived groups.
The deprivation gap in 10-year survival for men diagnosed
during the early 1990s was also very wide, at 11%.
Short-term prediction of the deprivation gap in 5- and
10-year survival between the most affluent and most deprived
groups suggests that the socioeconomic disparity in survival
may widen still further, to 20% or more, in the near future
(Table 2).
COMMENT
Survival from laryngeal cancer in men in England and Wales did
not increase rapidly in the 15 years to the end of the 20th century,
and such increases as did occur were virtually confined to men in
the most affluent sectors of society. The disparity in survival
between rich and poor is now the widest of any common cancer,
and it has worsened more rapidly than for any other cancer in
men. The deprivation-specific survival estimates take account of
socioeconomic differences in background mortality and trends in
those differences over time, just as in the analyses for other
cancers, so this unusually large increase in the inequality of cancer
survival demands an explanation.
Incidence trends in all socioeconomic groups were broadly
parallel, showing a gentle and symmetrical increase, plateau and
decline over the 14-year period 1986–1999 (Figure 3). The
incidence trends do not suggest an artefact of diagnosis or
registration that might account for the different survival trends
between socioeconomic groups.
The vast majority of laryngeal cancers are related to alcohol
and or tobacco, so the underlying risk of death in these
patients from any cause of death related to tobacco or alcohol
is probably even higher than that of men in the same socio-
economic group in the general population. Even life tables that
are specific to each socioeconomic group may therefore still
Table 1 Trends in relative survival (%) by time since diagnosis and calendar period of diagnosis: England and Wales, adults (15–99 years) diagnosed
during 1986–1999 and followed up to 2001
Calendar period of diagnosisa
Average change (%) Predictionc for patients
1986–1990 1991–1995 1996–1999 every 5 yearsb diagnosed during 2000–2001
Time since
diagnosis
Survival
(%) 95% CI
Survival
(%) 95% CI
Survival
(%) 95% CI
Survival
(%) 95% CI
Survival
(%) 95% CI
1 year Men 84.3 (83.3, 85.2) 83.9 (82.9, 84.8) 84.4 (83.3, 85.4) 1.2 (0.9, 3.2) 84.2 (82.6, 85.6)
5 years Men 63.9 (62.5, 65.3) 62.9 (61.5, 64.2) 64.3 (62.5, 66.1) 3.3* (0.0, 6.7) 63.9 (61.7, 66.1)
10 years Men 54.9 (53.2, 56.5) 54.4 (52.5, 56.2) 0.8 (8.1, 6.5) 55.4 (52.7, 57.9)
CI¼ confidence interval. aSurvival estimated with cohort or complete approach (see Rachet et al, 2008). bMean absolute change (%) in survival every 5 years, adjusted for
deprivation (see Rachet et al, 2008). cSurvival estimated with hybrid approach (see Rachet et al, 2008). *Po0.05.
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Figure 1 Relative survival (%) up to 10 years after diagnosis by calendar
period of diagnosis: England and Wales, adults (15–99 years) diagnosed
during 1986–1999 and followed up to 2001. Survival estimated with
cohort or complete approach (1986–1990, 1991–1995, 1996–1999) or
hybrid approach (2000–2001) (see Rachet et al, 2008).
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Figure 2 Trends in the deprivation gap in 5-year relative survival (%) by
calendar period of diagnosis: England and Wales, adults (15–99 years)
diagnosed during 1986–1999 and followed up to 2001.
Survival from cancer of the larynx in England and Wales
B Rachet et al
S36
British Journal of Cancer (2008) 99(S1), S35 – S37 & 2008 Cancer Research UK
under-estimate the true background mortality of these men to
some extent. Relative survival estimates on the basis of such life
tables, although they are in principle adjusted for mortality
not related to laryngeal cancer, may thus underestimate the
cancer-specific survival of men with laryngeal cancer to some
degree.
This cannot be the only explanation, however, as the same
life tables were used in the survival analyses for all cancers, and
the deprivation gap in survival for other cancers for which tobacco
or alcohol are causal factors (oesophagus, pancreas, kidney
and bladder) was stable, or did not increase nearly as much as it
did for laryngeal cancer. Further, the deprivation gap in 5-year
survival for laryngeal cancer seen in men diagnosed during
1986– 1990 (approximately 10%) had been fairly stable since the
1970s (Coleman et al, 1999), so deaths from other tobacco-related
causes cannot readily explain the increase in the deprivation
gradient for relative survival from laryngeal cancer during the
1990s. Life tables that are specific to such a group are not available,
but survival estimates made with approximate life tables for
smokers, derived from a cohort study (Cutler and Ederer, 1958),
do not suggest this could account for much of the difference in
relative survival.
The increasing difference in survival between socioeconomic
groups could thus reflect a deprivation gradient in the quality of
care for diseases related to alcohol and tobacco.
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Table 2 Trends in the deprivation gap in relative survival (%) by time since diagnosis and calendar period of diagnosis: England and Wales, adults
(15–99 years) diagnosed 1986–1999 and followed up to 2001
Calendar period of diagnosisa
Average change (%) Predictionc for patients
1986–1990 1991–1995 1996–1999 every 5 yearsb diagnosed during 2000–2001
Time since
diagnosis
Deprivation
gap (%) 95% CI
Deprivation
gap (%) 95% CI
Deprivation
gap (%) 95% CI
Deprivation
gap (%) 95% CI
Deprivation
gap (%) 95% CI
1 year Men 5.3** (8.1, 2.6) 5.6** (8.4, 2.9) 7.7** (10.8, 4.7) 1.2 (3.4, 0.9) 9.6** (13.9, 5.2)
5 years Men 9.6** (13.7, 5.4) 10.6** (14.6, 6.6) 17.2** (22.4, 11.9) 3.7* (7.1, 0.2) 21.5** (28.0, 15.1)
10 years Men 11.2** (16.2, 6.3) 11.1** (16.8, 5.5) 0.1 (7.4, 7.6) 23.4** (31.3, 15.6)
CI¼ confidence interval. aSurvival estimated with cohort or complete approach (see Rachet et al, 2008). bMean absolute change (%) in the deprivation gap in survival every
5 years, adjusted for the underlying trend in survival (see Rachet et al, 2008). cSurvival estimated with hybrid approach (see Rachet et al, 2008). *Po0.05; **Po0.01.
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Figure 3 Trends in the age-standardised incidence of laryngeal cancer in
men aged 15–99 years, by deprivation group: England and Wales, 1986–99.
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